Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone modifying activity	KAT5 JADE2 MECOM HUWE1 MIER1 GTF3C4 KMT2D NCOA1 TADA2A KDM4B	1.55e-05	229	159	10	GO:0140993
GeneOntologyMolecularFunction	transcription coregulator activity	SIN3B KAT5 PPRC1 SAP30L CHD4 RAD54L2 ACSS2 ARID1A MIER1 KMT2D SUPT7L AEBP2 NCOA1 TACC1 TADA2A	4.47e-05	562	159	15	GO:0003712
GeneOntologyMolecularFunction	histone acetyltransferase activity	KAT5 JADE2 GTF3C4 NCOA1 TADA2A	5.25e-05	51	159	5	GO:0004402
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	KAT5 JADE2 GTF3C4 NCOA1 TADA2A	7.58e-05	55	159	5	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	KAT5 JADE2 GTF3C4 NCOA1 TADA2A	1.15e-04	60	159	5	GO:0034212
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	AKAP6 SIN3B KAT5 MAP1A SYNM PPRC1 SAP30L CHD4 RAD54L2 ACSS2 ARID1A MIER1 RETREG3 SNAP29 KMT2D SYNE2 SUPT7L AEBP2 NCOA1 AKAP13 TACC1 TADA2A	1.35e-04	1160	159	22	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	AKAP6 DLGAP1 SIN3B KAT5 MAP1A SYNM PPRC1 SAP30L CHD4 RAD54L2 ACSS2 ARID1A MIER1 RETREG3 SNAP29 KMT2D SYNE2 SUPT7L AEBP2 NCOA1 GIGYF2 AKAP13 TACC1 TADA2A	1.86e-04	1356	159	24	GO:0060090
GeneOntologyMolecularFunction	chromatin binding	SOX9 SIN3B KAT5 GRWD1 TSPY4 SAP30L TSPY9 CHD4 ACSS2 ARID1A MSH6 NCOA1 TSPYL5 TADA2A SMAD6 RAD21	2.81e-04	739	159	16	GO:0003682
GeneOntologyMolecularFunction	N-acetyltransferase activity	KAT5 JADE2 GTF3C4 NCOA1 TADA2A	3.97e-04	78	159	5	GO:0008080
GeneOntologyMolecularFunction	transcription coactivator activity	KAT5 PPRC1 ACSS2 ARID1A KMT2D SUPT7L NCOA1 TACC1 TADA2A	7.39e-04	303	159	9	GO:0003713
GeneOntologyMolecularFunction	IgE receptor activity	MS4A2 FCER2	9.25e-04	6	159	2	GO:0019767
GeneOntologyMolecularFunction	mechanosensitive monoatomic cation channel activity	PIEZO1 TRPV4	1.29e-03	7	159	2	GO:0140135
GeneOntologyMolecularFunction	IgE binding	MS4A2 FCER2	1.29e-03	7	159	2	GO:0019863
GeneOntologyMolecularFunction	histone binding	GRWD1 TSPY4 SAP30L TSPY9 CHD4 MSH6 TSPYL5 DEK	1.31e-03	265	159	8	GO:0042393
GeneOntologyMolecularFunction	N-acyltransferase activity	KAT5 JADE2 GTF3C4 NCOA1 TADA2A	1.35e-03	102	159	5	GO:0016410
GeneOntologyMolecularFunction	acetyltransferase activity	KAT5 JADE2 GTF3C4 NCOA1 TADA2A	1.47e-03	104	159	5	GO:0016407
GeneOntologyBiologicalProcess	chromatin remodeling	SOX9 KAT5 GRWD1 JADE2 BICRA TSPY4 MECOM TSPY9 CHD4 HUWE1 RAD54L2 ARID1A MIER1 GTF3C4 KMT2D UBN1 NCOA1 TSPYL5 TADA2A DEK KDM4B	1.76e-07	741	155	21	GO:0006338
GeneOntologyBiologicalProcess	chromatin organization	SOX9 KAT5 GRWD1 JADE2 BICRA TSPY4 MECOM TSPY9 CHD4 HUWE1 RAD54L2 ARID1A MIER1 GTF3C4 KMT2D UBN1 AEBP2 NCOA1 TSPYL5 TADA2A DEK KDM4B RAD21	2.52e-07	896	155	23	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	SOX9 KAT5 GRWD1 JADE2 BICRA TSPY4 MECOM TSPY9 CHD4 HUWE1 RAD54L2 ARID1A MIER1 GTF3C4 KMT2D UBN1 AEBP2 NCOA1 TSPYL5 TADA2A DEK KDM4B RAD21	1.65e-06	999	155	23	GO:0071824
GeneOntologyCellularComponent	chromatin	SOX9 MYF6 BNC2 SIN3B GSX1 KAT5 JADE2 BICRA TSPY4 SAP30L TSPY9 CHD4 RFX8 ARID1A MSH6 ZFHX4 SUPT7L AEBP2 PLCB1 NCOA1 TSPYL5 TADA2A MGA DEK KDM4B SMAD6 RAD21	1.67e-05	1480	158	27	GO:0000785
GeneOntologyCellularComponent	histone deacetylase complex	SIN3B KAT5 SAP30L MECOM CHD4 ZNF217	4.53e-05	85	158	6	GO:0000118
GeneOntologyCellularComponent	calcium channel complex	AKAP6 CACNA1F PDE4D CACNA2D4 PKD1	2.30e-04	73	158	5	GO:0034704
GeneOntologyCellularComponent	radial spoke 1	RSPH4A RSPH3	3.37e-04	4	158	2	GO:0120333
GeneOntologyCellularComponent	radial spoke 3	RSPH4A RSPH3	3.37e-04	4	158	2	GO:0120335
GeneOntologyCellularComponent	radial spoke head 1	RSPH4A RSPH3	3.37e-04	4	158	2	GO:0120336
GeneOntologyCellularComponent	radial spoke head 3	RSPH4A RSPH3	3.37e-04	4	158	2	GO:0120338
GeneOntologyCellularComponent	ATPase complex	ATP6V0A1 KAT5 BICRA CHD4 ARID1A DEK	4.49e-04	129	158	6	GO:1904949
GeneOntologyCellularComponent	GATOR1 complex	SZT2 NPRL3	5.59e-04	5	158	2	GO:1990130
GeneOntologyCellularComponent	radial spoke head	RSPH4A RSPH3	5.59e-04	5	158	2	GO:0001535
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	KAT5 BICRA CHD4 ARID1A DEK	8.14e-04	96	158	5	GO:0070603
GeneOntologyCellularComponent	mitotic spindle	MYF6 KAT5 NEIL2 HECW2 PKHD1 TADA2A TUBB8B	8.59e-04	201	158	7	GO:0072686
MousePheno	ventricular septal defect	BICRA NTRK3 MECOM CHD4 ARID1A PKD1 NPRL3 SYT1 MAPK7 PRRC2B TP53BP2 SMAD6	3.48e-06	261	124	12	MP:0010402
MousePheno	abnormal interventricular septum morphology	BICRA NTRK3 MECOM CHD4 ARID1A MYLK3 PKD1 NPRL3 SYT1 MAPK7 PRRC2B TP53BP2 SMAD6	1.07e-05	342	124	13	MP:0000281
MousePheno	abnormal heart septum morphology	BICRA NTRK3 MECOM CHD4 ARID1A MYLK3 PKD1 NPRL3 SYT1 MAPK7 PRRC2B TP53BP2 SMAD6	4.01e-05	388	124	13	MP:0006113
Domain	HECT	HECW1 HUWE1 HECW2 HERC2	6.73e-05	27	154	4	PF00632
Domain	HECTc	HECW1 HUWE1 HECW2 HERC2	6.73e-05	27	154	4	SM00119
Domain	HECT_dom	HECW1 HUWE1 HECW2 HERC2	6.73e-05	27	154	4	IPR000569
Domain	HECT	HECW1 HUWE1 HECW2 HERC2	6.73e-05	27	154	4	PS50237
Domain	HECW_N	HECW1 HECW2	6.75e-05	2	154	2	IPR032348
Domain	HECW_N	HECW1 HECW2	6.75e-05	2	154	2	PF16562
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	KAT5 JADE2 SAP30L MECOM CHD4 ARID1A KMT2D SUPT7L AEBP2 NCOA1 TADA2A KDM4B	1.37e-06	272	110	12	M29619
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	JADE2 SAP30L CHD4 ARID1A KMT2D AEBP2 NCOA1 KDM4B	6.71e-05	175	110	8	MM14941
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NES DLGAP1 SIN3B NYAP2 HECW1 TRIO MINK1 AAK1 APC CHD4 HUWE1 EDC4 ARMCX4 KIAA1217 NCAN SYNE2 NGEF ZSCAN18 PLCB1 NAV1 SYT1 GIGYF2 HERC2 CTNND1 RAPGEF2 MGA PRRC2B TP53BP2	8.34e-15	963	161	28	28671696
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPIRE2 PCNX3 TRIO SZT2 MFHAS1 PPRC1 BICRA PIEZO1 KHNYN WDR70 LRRK1 HUWE1 EDC4 ARID1A ADGRA2 THADA KMT2D UBN1 PLEKHM2 KANK3 PKD1 TMEM268 NPRL3 NAV1 LRP3 AKAP13 HERC2 PKN3 PRRC2B	3.53e-14	1105	161	29	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NES SPIRE2 CARMIL2 TRIO RIMKLA RASSF2 NTRK3 MINK1 AAK1 APC KIAA1191 EDC4 SPECC1 MYLK3 KIAA1217 SYNE2 NAV1 GIGYF2 AKAP13 CTNND1 RAPGEF2 TP53BP2	9.66e-11	861	161	22	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SIN3B APC MECOM CHD4 ZNF217 HUWE1 GTF3C4 KMT2D ZFHX4 PPM1F NAV1 GIGYF2 TADA2A MGA TP53BP2	1.23e-09	418	161	15	34709266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NES DLGAP1 ATP6V0A1 PDE4D CARMIL2 MAP1A TRIO MINK1 ZNF185 AAK1 APC EDC4 ARID1A YJEFN3 SPECC1 HECW2 KIAA1217 NCAN NGEF NAV1 PACS2 SYT1 CTNND1 RAPGEF2 PRRC2B TP53BP2	2.51e-09	1431	161	26	37142655
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AKAP6 HECW1 SYNM KHNYN HUWE1 HERC2 CTNND1 RAPGEF2	3.13e-08	104	161	8	9205841
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SIN3B SYNM KHNYN APC ARID1A KIAA1217 GIGYF2 TACC1 CTNND1 PRRC2B TP53BP2	4.60e-08	263	161	11	34702444
Pubmed	Human transcription factor protein interaction networks.	SOX9 SIN3B KAT5 BICRA MECOM ZNF217 EDC4 RAD54L2 ARID1A MIER1 ANGPTL6 KMT2D UBN1 ZFHX4 SYNE2 SUPT7L ZSCAN18 NCOA1 GIGYF2 TADA2A HERC2 MGA PRRC2B RAD21	4.88e-08	1429	161	24	35140242
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	TRIO CHD4 ZNF217 HUWE1 ARID1A GTF3C4 TRMU UBN1 NAV1 TACC1 PRRC2B TP53BP2	5.49e-08	332	161	12	37433992
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	NES TRIO SLC43A1 WDR70 APC MECOM HUWE1 KIAA1191 MCM10 GTF3C4 NAV1 UGGT2 AKAP13 TACC1 CTNND1 MGA PKN3	6.09e-08	733	161	17	34672954
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DLGAP1 ATP6V0A1 MAP1A MINK1 AAK1 APC ACSS2 SPECC1 NGEF PLCB1 GIGYF2 CTNND1	8.87e-08	347	161	12	17114649
Pubmed	Interaction network of human early embryonic transcription factors.	KAT5 BICRA MECOM ZNF217 RAD54L2 ARID1A KMT2D ZFHX4 NCOA1 TADA2A MGA PRRC2B	1.00e-07	351	161	12	38297188
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ZFYVE27 SYNM MINK1 APC MUC16 CHD4 HUWE1 MCM10 SNAP29 THADA PLEKHM2 SLC19A1 TACC1 CTNND1 RAPGEF2 MGA PRRC2B	1.39e-07	777	161	17	35844135
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	SOX9 SIN3B WDR70 CHD4 MCM10 MIER1 GTF3C4 MSH6 UBN1 ZSCAN18 HERC2 MGA DEK KDM4B RAD21	1.73e-07	608	161	15	36089195
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AKAP6 NYAP2 SZT2 JADE2 PIEZO1 AAK1 LRRK1 ADGRA2 MIER1 PPM1F HECW2 PLCB1 KDM4B RAD21	1.96e-07	529	161	14	14621295
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A SYNM MECOM ZNF217 KMT2D UBN1 NAV1 GIGYF2 MGA	2.13e-07	184	161	9	32908313
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	BICRA APC MECOM ZNF217 ARID1A KMT2D ZFHX4 SYNE2 AEBP2 NCOA1 MGA KDM4B	3.85e-07	398	161	12	35016035
Pubmed	The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.	AKAP6 PDE4D MAPK7	3.88e-07	4	161	3	16177794
Pubmed	A human MAP kinase interactome.	DLGAP1 MAP1A JADE2 BICRA APC PLCB1 NAV1 GIGYF2 AKAP13 HERC2 RAPGEF2 MAPK7 MGA	4.83e-07	486	161	13	20936779
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	SIN3B CHD4 ZNF217 ARID1A GTF3C4 KMT2D SUPT7L NCOA1 MGA PRRC2B	5.46e-07	268	161	10	33640491
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 SOX9 DLGAP1 ATP6V0A1 TRIO SYNM JADE2 PPRC1 APC CHD4 HUWE1 ARMCX4 RAD54L2 ARID1A SPECC1 GTF3C4 THAP4 PKD1 NGEF HERC2 RAPGEF2	5.68e-07	1285	161	21	35914814
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MINK1 AAK1 SAP30L CHD4 ZNF217 HUWE1 TSSC4 MIER1 GTF3C4 MSH6 KMT2D UBN1 EIF2B5 PACS2 GIGYF2 KDM4B	7.01e-07	774	161	16	15302935
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	DLGAP1 PDE4D MAP1A TRIO NTRK3 MINK1 AAK1 NCAN RAPGEF2 TP53BP2	8.39e-07	281	161	10	28706196
Pubmed	Chromodomain helicase binding protein 8 (Chd8) is a novel A-kinase anchoring protein expressed during rat cardiac development.	AKAP6 SYNM AKAP13	9.67e-07	5	161	3	23071553
Pubmed	The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer.	CHD4 HUWE1 MSH6 HERC2 DEK RAD21	1.00e-06	71	161	6	29346117
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	KAT5 MAP1A BICRA SAP30L MECOM CHD4 ARID1A SNAP29 MSH6 ZNF469 THADA ZFHX4 SUPT7L RTL9 TIGD5 TADA2A RAPGEF2 MGA PRRC2B	1.13e-06	1116	161	19	31753913
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	AAMP PDE4D MAP1A HUWE1 HERC2 MGA	1.50e-06	76	161	6	27542412
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PDE4D TRIO JADE2 BICRA MINK1 WDR70 AAK1 HUWE1 ARID1A YJEFN3 SNAP29 THAP4 THADA PTPRG SLC19A1 KIAA1217 NGEF NAV1 AKAP13 CTNND1 RAPGEF2 KDM4B	1.59e-06	1489	161	22	28611215
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SIN3B MAP1A WDR70 AAK1 CHD4 EDC4 GTF3C4 SNAP29 MSH6 KIAA1217 GIGYF2 TACC1 CTNND1 PKN3 PRRC2B TP53BP2 RAD21	1.76e-06	934	161	17	33916271
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SIN3B HUWE1 EDC4 ARID1A GTF3C4 SNAP29 MSH6 KMT2D GIGYF2 CTNND1 MGA PRRC2B TP53BP2	1.87e-06	549	161	13	38280479
Pubmed	Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation.	PKD1 PACS2 TRPV4	1.93e-06	6	161	3	15692563
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	AAMP PCNX3 PIEZO1 CASP4 MECOM KIAA1191 SPECC1 TRMU UBN1 NCAN PKD1 HERC2 CTNND1 RAPGEF2 DEK PKN3 PRRC2B YIPF6 SMAD6	3.87e-06	1215	161	19	15146197
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NES ZNF185 WDR70 AAK1 RIOK3 CHD4 HUWE1 MCM10 TSSC4 ARID1A GTF3C4 MSH6 UBN1 PPM1F EIF2B5 AKAP13 HERC2 CTNND1 MGA TP53BP2	4.90e-06	1353	161	20	29467282
Pubmed	Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-α axis.	SOX9 PIEZO1 TRPV4	5.36e-06	8	161	3	34624205
Pubmed	System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.	HECW1 HUWE1 HECW2 HERC2	6.11e-06	26	161	4	26949039
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DLGAP1 NYAP2 HECW1 MAP1A TRIO MINK1 AAK1 APC HUWE1 EDC4 SNAP29 GSPT2 KIAA1217 PLCB1 NAV1 SYT1 TACC1 CTNND1	6.14e-06	1139	161	18	36417873
Pubmed	New nomenclature for chromatin-modifying enzymes.	KAT5 GTF3C4 KMT2D NCOA1 KDM4B	6.89e-06	57	161	5	18022353
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PPRC1 PLCB1 PACS2 MGA PRRC2B MAST3	9.88e-06	105	161	6	9628581
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	SIN3B EIF2B5 NGEF NAV1 MGA DEK	1.22e-05	109	161	6	33554859
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	SIN3B TRIO WDR70 APC NGEF PLCB1 HERC2 RAPGEF2 PRRC2B MAST3 RAD21	1.46e-05	475	161	11	31040226
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SIN3B HECW1 SYNM RASSF2 KIAA1191 THADA TTBK1 SOCS5 TSPYL5 MGA MAST3	2.05e-05	493	161	11	15368895
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MAP1A APC MECOM RIOK3 ZNF217 HUWE1 RAD54L2 ARID1A UBN1 KIAA1217 NAV1 PRRC2B	2.07e-05	588	161	12	38580884
Pubmed	TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.	RFX8 PLCB1 TSPYL5	2.08e-05	12	161	3	23518928
Pubmed	p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia.	APC CTNND1	2.13e-05	2	161	2	29130932
Pubmed	The roles of mechanosensitive ion channels and associated downstream MAPK signaling pathways in PDLC mechanotransduction.	PIEZO1 TRPV4	2.13e-05	2	161	2	32323761
Pubmed	Independent endothelial functions of PIEZO1 and TRPV4 in hepatic portal vein and predominance of PIEZO1 in mechanical and osmotic stress.	PIEZO1 TRPV4	2.13e-05	2	161	2	37349903
Pubmed	Functional role for Piezo1 in stretch-evoked Ca²⁺ influx and ATP release in urothelial cell cultures.	PIEZO1 TRPV4	2.13e-05	2	161	2	24759099
Pubmed	Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma.	ZNF217 ARID1A	2.13e-05	2	161	2	24336158
Pubmed	PIEZO1 and TRPV4, which Are Distinct Mechano-Sensors in the Osteoblastic MC3T3-E1 Cells, Modify Cell-Proliferation.	PIEZO1 TRPV4	2.13e-05	2	161	2	31597314
Pubmed	The DNA Glycosylase NEIL2 Suppresses Fusobacterium-Infection-Induced Inflammation and DNA Damage in Colonic Epithelial Cells.	NEIL2 APC	2.13e-05	2	161	2	32872214
Pubmed	The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.	PKD1 PKHD1	2.13e-05	2	161	2	11919560
Pubmed	Direct measurement of TRPV4 and PIEZO1 activity reveals multiple mechanotransduction pathways in chondrocytes.	PIEZO1 TRPV4	2.13e-05	2	161	2	28135189
Pubmed	The rat heart contains a neural stem cell population; role in sympathetic sprouting and angiogenesis.	SOX9 NES	2.13e-05	2	161	2	18718475
Pubmed	Chd4 and associated proteins function as corepressors of Sox9 expression during BMP-2-induced chondrogenesis.	SOX9 CHD4	2.13e-05	2	161	2	23519980
Pubmed	Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice.	PIEZO1 TRPV4	2.13e-05	2	161	2	35451372
Pubmed	Piezo1 acts upstream of TRPV4 to induce pathological changes in endothelial cells due to shear stress.	PIEZO1 TRPV4	2.13e-05	2	161	2	33298523
Pubmed	Functional Expression of Mechanosensitive Piezo1/TRPV4 Channels in Mouse Osteoblasts.	PIEZO1 TRPV4	2.13e-05	2	161	2	36792153
Pubmed	Piezo1 channels mediate trabecular meshwork mechanotransduction and promote aqueous fluid outflow.	PIEZO1 TRPV4	2.13e-05	2	161	2	33226641
Pubmed	Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and β-Catenin-Independent Targets by Proteomics.	MINK1 APC	2.13e-05	2	161	2	31160382
Pubmed	[Involvement of the Piezo1 and TRPV4 stretch-activated channels in pulmonary hypertension].	PIEZO1 TRPV4	2.13e-05	2	161	2	35151521
Pubmed	ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription.	APC ARID1A	2.13e-05	2	161	2	33084574
Pubmed	Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease.	PKD1 PKHD1	2.13e-05	2	161	2	28578020
Pubmed	Activation of the Mechanosensitive Ion Channels Piezo1 and TRPV4 in Primary Human Healthy and Osteoarthritic Chondrocytes Exhibits Ion Channel Crosstalk and Modulates Gene Expression.	PIEZO1 TRPV4	2.13e-05	2	161	2	37175575
Pubmed	A Mutation in Syne2 Causes Early Retinal Defects in Photoreceptors, Secondary Neurons, and Müller Glia.	IFNGR1 SYNE2	2.13e-05	2	161	2	26066746
Pubmed	Loss of PACS-2 delays regeneration in DSS-induced colitis but does not affect the ApcMin model of colorectal cancer.	APC PACS2	2.13e-05	2	161	2	29312533
Pubmed	Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.	SOX9 KAT5	2.13e-05	2	161	2	18390577
Pubmed	Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.	SOX9 NES	2.13e-05	2	161	2	19845757
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	DLGAP1 TRIO MINK1 NCAN PLCB1 SYT1 CTNND1 RAPGEF2	2.39e-05	251	161	8	27507650
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	SIN3B CHD4 MIER1 SUPT7L MGA DEK	2.55e-05	124	161	6	20850016
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	CHD4 ZNF217 RAD54L2 GTF3C4 SUPT7L MGA	2.67e-05	125	161	6	32891193
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	AAMP GRWD1 KHNYN WDR70 AAK1 RIOK3 KIAA1191 EDC4 SNAP29 KIAA1217 EIF2B5 GIGYF2 CTNND1 RAPGEF2 MAPK7 DEK	2.80e-05	1038	161	16	26673895
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SOX9 SIN3B JADE2 ZNF185 CHD4 ZNF217 ARID1A ZNF358 SEBOX NCOA1 TIGD5 ZBTB3 KDM4B	2.84e-05	709	161	13	22988430
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	DUSP9 MUC16 LRRK1 SPAG8 MIER1 PPM1F HECW2 KIAA1217 GIGYF2 HERC2	2.85e-05	420	161	10	28065597
Pubmed	A SMAD1/5-YAP signalling module drives radial glia self-amplification and growth of the developing cerebral cortex.	SOX9 APC ARID1A NAV1	2.89e-05	38	161	4	32541003
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	SIN3B KAT5 GRWD1 CHD4 ZNF217 MCM10 GTF3C4 SUPT7L MGA	3.11e-05	339	161	9	30415952
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TRIO MINK1 DUSP9 HID1 HUWE1 ARID1A MSH6 KMT2D PTPRG PPM1F SYNE2 HERC2 CTNND1 DEK PRRC2B TP53BP2	3.18e-05	1049	161	16	27880917
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SIN3B KAT5 GRWD1 SAP30L MECOM CHD4 ARID1A MIER1 GTF3C4 THAP4 KMT2D UBN1 SUPT7L TIGD5 TADA2A MGA DEK RAD21	3.36e-05	1294	161	18	30804502
Pubmed	A protein interaction landscape of breast cancer.	TRIO BICRA ZNF185 MCM10 ARID1A SPECC1 GTF3C4 MSH6 AEBP2 TSPYL5 CTNND1 RAD21	4.30e-05	634	161	12	34591612
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	AAMP NYAP2 MUC16 ARID1A KMT2D PPM1F SYNE2 SUPT7L PLCB1 NCOA1 TIGD5 PRRC2B	4.56e-05	638	161	12	31182584
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SIN3B KAT5 DUSP9 WDR70 SAP30L MECOM CHD4 HUWE1 GTF3C4 KMT2D ZFHX4 CTNND1 MGA DEK	4.89e-05	857	161	14	25609649
Pubmed	Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.	SIN3B SAP30L CHD4 MIER1	5.68e-05	45	161	4	21258344
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP1A TRIO APC KIAA1191 EDC4 CTNND1 TP53BP2	5.71e-05	209	161	7	36779422
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SIN3B GRWD1 BICRA CHD4 ZNF217 EDC4 RAD54L2 ARID1A THAP4 MSH6 KMT2D NCOA1 ZBTB3 DEK PRRC2B RAD21	5.76e-05	1103	161	16	34189442
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	BNC2 CHD4 ARID1A MSH6 KIAA1217 MGA	6.37e-05	146	161	6	23892456
Pubmed	cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3.	AKAP6 PDE4D	6.37e-05	3	161	2	20106966
Pubmed	Characterization of PKD protein-positive exosome-like vesicles.	PKD1 PKHD1	6.37e-05	3	161	2	19158352
Pubmed	The oscillation of intracellular Ca2+ influx associated with the circadian expression of Piezo1 and TRPV4 in the bladder urothelium.	PIEZO1 TRPV4	6.37e-05	3	161	2	29632308
Pubmed	Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins.	APC MSH6	6.37e-05	3	161	2	19029948
Pubmed	Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).	AKAP6 PDE4D	6.37e-05	3	161	2	23806656
Pubmed	A Discrete Subset of Monocyte-Derived Cells among Typical Conventional Type 2 Dendritic Cells Can Efficiently Cross-Present.	APC CSF2RB	6.37e-05	3	161	2	29091760
Pubmed	E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.	APC HUWE1	6.37e-05	3	161	2	28137882
Pubmed	Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells.	ARID1A KMT2D	6.37e-05	3	161	2	27387124
Pubmed	APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells.	APC CTNND1	6.37e-05	3	161	2	33237836
Pubmed	Transforming Growth Factor-β-Induced KDM4B Promotes Chondrogenic Differentiation of Human Mesenchymal Stem Cells.	SOX9 KDM4B	6.37e-05	3	161	2	26485430
Pubmed	The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis.	APC MSH6	6.37e-05	3	161	2	11691815
Pubmed	Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.	SOX9 MECOM	6.37e-05	3	161	2	27991928
Pubmed	SOX9 directly regulates IGFBP-4 in the intestinal epithelium.	SOX9 APC	6.37e-05	3	161	2	23660500
Pubmed	Transcription of the mouse RFC-1 gene encoding a folate transporter. Multiplicity and properties of promoters with minimum requirements for their basal activity.	IFNGR1 SLC19A1	6.37e-05	3	161	2	10231581
Pubmed	Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.	APC KMT2D	6.37e-05	3	161	2	32024448
Pubmed	Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs).	PKD1 PKHD1	6.37e-05	3	161	2	32001768
Interaction	TNIK interactions	NES DLGAP1 TRIO NTRK3 MINK1 APC HUWE1 EDC4 KIAA1217 SYNE2 NGEF ZSCAN18 HERC2 CTNND1 MGA PRRC2B	4.25e-08	381	155	16	int:TNIK
Interaction	YWHAH interactions	NES DLGAP1 SPIRE2 CARMIL2 TRIO RIMKLA RASSF2 MINK1 AAK1 APC HUWE1 KIAA1191 EDC4 SPECC1 KIAA1217 SYNE2 NAV1 NCOA1 PACS2 GIGYF2 AKAP13 CTNND1 RAPGEF2 MAPK7 MAST3 TP53BP2	3.07e-07	1102	155	26	int:YWHAH
Interaction	PHF21A interactions	SIN3B APC MECOM ZNF217 HUWE1 KMT2D ZFHX4 PPM1F NAV1 GIGYF2 TADA2A MGA PKN3 TP53BP2	4.38e-07	343	155	14	int:PHF21A
Interaction	CRX interactions	KAT5 SZT2 NEIL2 BICRA MECOM ZNF217 ARID1A KMT2D ZFHX4 NCOA1 MGA PRRC2B	6.54e-07	254	155	12	int:CRX
Interaction	TOP3B interactions	SPIRE2 GRWD1 PCNX3 TRIO SZT2 MFHAS1 PPRC1 BICRA PIEZO1 KHNYN WDR70 LRRK1 HUWE1 EDC4 ARID1A ADGRA2 THADA KMT2D UBN1 PLEKHM2 KANK3 PKD1 TMEM268 NPRL3 NAV1 LRP3 AKAP13 HERC2 PKN3 PRRC2B	7.36e-07	1470	155	30	int:TOP3B
Interaction	EGR2 interactions	BICRA MECOM ZNF217 RAD54L2 ARID1A KMT2D ZFHX4 NCOA1 MGA PRRC2B	8.46e-07	171	155	10	int:EGR2
Interaction	SYNGAP1 interactions	DLGAP1 NYAP2 MAP1A NTRK3 MINK1 AAK1 HUWE1 SPAG8 NCAN SYNE2 AKAP13 RAPGEF2	4.70e-06	307	155	12	int:SYNGAP1
Interaction	RCOR1 interactions	SIN3B APC MECOM CHD4 ZNF217 HUWE1 MIER1 MSH6 KMT2D ZFHX4 GIGYF2 TADA2A MGA PKN3 TP53BP2	6.59e-06	494	155	15	int:RCOR1
Interaction	MAPRE3 interactions	MAP1A TRIO MINK1 APC MCM10 SPECC1 TTBK1 KIAA1217 NAV1 TACC1	1.19e-05	230	155	10	int:MAPRE3
Interaction	HNF1B interactions	SOX9 BICRA ZNF217 ARID1A KMT2D UBN1 ZFHX4 MGA PRRC2B	1.68e-05	190	155	9	int:HNF1B
Interaction	PPARG interactions	KAT5 MFHAS1 BICRA EDC4 RAD54L2 KMT2D NCOA1 SYT1 GIGYF2 TADA2A ZBTB3	2.65e-05	307	155	11	int:PPARG
Interaction	FEV interactions	BICRA MECOM ZNF217 RAD54L2 ARID1A KMT2D ZFHX4 MGA PRRC2B	2.83e-05	203	155	9	int:FEV
Interaction	ATOH1 interactions	AAMP PDE4D MAP1A HUWE1 HERC2 MGA	3.53e-05	80	155	6	int:ATOH1
Interaction	MEX3A interactions	TRIO CHD4 ZNF217 HUWE1 ARID1A GTF3C4 TRMU UBN1 NAV1 TACC1 PRRC2B TP53BP2	4.34e-05	384	155	12	int:MEX3A
Interaction	KCTD13 interactions	NES DLGAP1 ATP6V0A1 PDE4D CARMIL2 MAP1A TRIO MINK1 ZNF185 AAK1 APC EDC4 ARID1A SPECC1 HECW2 KIAA1217 NCAN NGEF NAV1 PACS2 SYT1 CTNND1 RAPGEF2 PRRC2B TP53BP2	6.20e-05	1394	155	25	int:KCTD13
Interaction	YWHAZ interactions	DLGAP1 SPIRE2 PDE4D CARMIL2 RASSF2 MINK1 AAK1 APC HUWE1 ARID1A SPECC1 CSF2RB SYNE2 NAV1 PACS2 GIGYF2 AKAP13 HERC2 CTNND1 RAPGEF2 MAPK7 DEK MAST3 TP53BP2	7.08e-05	1319	155	24	int:YWHAZ
Interaction	SRRM1 interactions	NES WDR70 CHD4 HUWE1 KMT2D SYNE2 AKAP13 TADA2A HERC2 DEK RAD21	8.22e-05	348	155	11	int:SRRM1
Interaction	YWHAG interactions	DLGAP1 SPIRE2 KAT5 CARMIL2 RIMKLA RASSF2 MINK1 AAK1 APC HUWE1 EDC4 SPECC1 TTBK1 SYNE2 NAV1 PACS2 GIGYF2 AKAP13 CTNND1 RAPGEF2 MAPK7 MAST3 TP53BP2	8.41e-05	1248	155	23	int:YWHAG
Interaction	ARHGAP42 interactions	SYNE2 NGEF AKAP13 RAPGEF2 DEK	9.80e-05	60	155	5	int:ARHGAP42
Interaction	NCKAP5 interactions	APC MCM10 HECW2 HERC2	1.02e-04	32	155	4	int:NCKAP5
Interaction	KDM1A interactions	SIN3B RASSF2 APC MECOM CHD4 ZNF217 HUWE1 GTF3C4 MSH6 KMT2D ZFHX4 PPM1F KIAA1217 NAV1 GIGYF2 TACC1 TADA2A MGA TP53BP2	1.15e-04	941	155	19	int:KDM1A
Interaction	RNF43 interactions	SIN3B HECW1 SYNM KHNYN APC ARID1A KIAA1217 GIGYF2 TACC1 CTNND1 PRRC2B TP53BP2	1.19e-04	427	155	12	int:RNF43
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC ARMCX4 THADA CTNND1	9.58e-05	43	101	4	409
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT5 GTF3C4 NCOA1	1.09e-04	17	101	3	486
GeneFamily	Intermediate filaments Type IV	NES SYNM	4.57e-04	6	101	2	611
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP6 SYNM AKAP13	5.56e-04	29	101	3	396
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	FCER2 NCAN PKD1	1.55e-03	41	101	3	1298
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	SLC19A1 AKAP13 PKN3	2.90e-03	51	101	3	870
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	BNC2 DLGAP1 PDE4D TRIO PTPRG KIAA1217 SYNE2 PKHD1 AKAP13 RAPGEF2	1.30e-07	176	159	10	M39223
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	SZT2 PPRC1 BICRA MINK1 ARHGAP30 RAD54L2 TRMU KMT2D ZNF358 SUPT7L CTNND1	7.38e-06	338	159	11	M17094
ToppCell	Bronchial_Biopsy-Immune-Neutrophils\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	EBLN2 ZNF469 SLC19A1 TMEM268 AEBP2 LRP3 TIGD5 MAPK7 ZBTB3	8.13e-09	162	161	9	985adca17b0c99563feef7910f3da5df31e636b6
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	PDE4D MECOM PTPRG SYNE2 PLCB1 TACC1 RAPGEF2 PKN3 SMAD6	2.83e-08	187	161	9	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NES COL15A1 IFNGR1 PTPRG HECW2 SYNE2 AKAP13 TACC1 RAPGEF2	5.04e-08	200	161	9	46dac23d8f9d426fe52ad6dac9c15ce91e615762
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MECOM PTPRG KIAA1217 SYNE2 PLCB1 TACC1 RAPGEF2 SMAD6	3.00e-07	179	161	8	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MECOM PTPRG HECW2 KIAA1217 SYNE2 PLCB1 TACC1 RAPGEF2	4.53e-07	189	161	8	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	COVID-19-Heart-Mito_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYBPH MYF6 NES COL15A1 MAP1A SYNM PERM1 PLCB1	4.72e-07	190	161	8	ea74e0e38bcaba125b48c88331e9ba09228d3178
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PDE4D TRIO PTPRG SYNE2 PKHD1 AKAP13 RAPGEF2	5.11e-07	192	161	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	COPD-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	BNC2 PDE4D COL15A1 TRIO MFHAS1 SYNE2 PLCB1 PRRC2B	5.53e-07	194	161	8	8dcde77767b23e75360adb316cdccf56a00e3726
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	DLGAP1 PDE4D MFHAS1 AAK1 IFNGR1 CACNA2D4 SYNE2 PLCB1	5.53e-07	194	161	8	4547b57669be5d4f0de55175802ee04372288a6a
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	MECOM HECW2 KIAA1217 KANK3 SYNE2 PLCB1 TACC1 RAPGEF2	5.74e-07	195	161	8	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NES COL15A1 MECOM HID1 HECW2 KIAA1217 KANK3 CTNND1	6.20e-07	197	161	8	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	BNC2 COL15A1 TRIO MFHAS1 MECOM SYNE2 PLCB1 AKAP13	6.45e-07	198	161	8	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	NES HECW2 KIAA1217 KANK3 SYNE2 PLCB1 NAV1 SMAD6	6.70e-07	199	161	8	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	PDE4D MECOM SPECC1 PTPRG SYNE2 PLCB1 TACC1 SMAD6	6.95e-07	200	161	8	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	PDE4D RIOK3 CHD4 MIER1 SYNE2 AKAP13 TACC1 RAD21	6.95e-07	200	161	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SIN3B SZT2 CHD4 ARID1A GIGYF2 MGA CCDC191	2.48e-06	166	161	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	PTPRG HECW2 KIAA1217 SYNE2 PLCB1 PKN3 SMAD6	4.39e-06	181	161	7	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 COL15A1 MECOM SPECC1 PTPRG PLCB1 NAV1	4.56e-06	182	161	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	NES HECW2 KIAA1217 KANK3 NAV1 PKN3 SMAD6	5.26e-06	186	161	7	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 DLGAP1 MFHAS1 PTPRG SYNE2 PKHD1 PLCB1	5.44e-06	187	161	7	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYF6 NES SYNM PCDHGA7 IFNGR1 HECW2 KANK3	5.64e-06	188	161	7	fe7143c36e4a883745862d3c3147cf751b440e46
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYF6 NES SYNM PCDHGA7 IFNGR1 HECW2 KANK3	5.64e-06	188	161	7	cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM LRRK1 RFX8 PLCB1 NAV1 PKN3 SMAD6	5.84e-06	189	161	7	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 COL15A1 SYNM MYLK3 PTPRG PLCB1 NAV1	6.04e-06	190	161	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM LRRK1 SPECC1 PLCB1 NAV1 PKN3 SMAD6	6.25e-06	191	161	7	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	MECOM KIAA1217 SYNE2 PLCB1 TACC1 PKN3 SMAD6	6.25e-06	191	161	7	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	droplet-Heart\|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES MECOM IFNGR1 PPM1F KANK3 TACC1 SMAD6	6.47e-06	192	161	7	67a7e07a11091120edbccf739836235c422ec9c6
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	BNC2 COL15A1 MECOM SPECC1 PLCB1 UGGT2 TACC1	6.47e-06	192	161	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NES PTPRG HECW2 KIAA1217 KANK3 NAV1 SMAD6	6.69e-06	193	161	7	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	367C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NES IFNGR1 PTPRG HECW2 KIAA1217 NAV1 SMAD6	6.69e-06	193	161	7	5c6b03d6d98aa873fda1a201d44a912246bb5a92
ToppCell	367C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NES IFNGR1 PTPRG HECW2 KIAA1217 NAV1 SMAD6	6.69e-06	193	161	7	d4b58eee97043b4337ec36c40f9af6499d864df9
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	MECOM KIAA1217 SYNE2 PLCB1 TACC1 PKN3 SMAD6	7.16e-06	195	161	7	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL15A1 MECOM ADGRA2 HECW2 KANK3 PKN3 SMAD6	7.16e-06	195	161	7	4658fb197657d7692ee344ae76b11b0210c418ba
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL15A1 MECOM PTPRG PLCB1 NCOA1 UGGT2 TACC1	7.16e-06	195	161	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRG HECW2 KANK3 PLCB1 NAV1 TACC1 SMAD6	7.40e-06	196	161	7	4cd1e6b7a791e11a40b19f971b7011bd11fe6273
ToppCell	IPF-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	NES IFNGR1 PTPRG HECW2 KIAA1217 NAV1 SMAD6	7.40e-06	196	161	7	8f0f72ead06abe02b575e443552eacc2151077ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRG HECW2 KANK3 PLCB1 NAV1 TACC1 SMAD6	7.40e-06	196	161	7	d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES COL15A1 HECW2 KANK3 PLCB1 TACC1 SMAD6	7.65e-06	197	161	7	c29ed0e706999d4c2b93e6e3bf46c42aeceb4813
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	MECOM KIAA1217 SYNE2 PLCB1 TACC1 PKN3 SMAD6	7.65e-06	197	161	7	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	metastatic_Brain-Endothelial_cells\|metastatic_Brain / Location, Cell class and cell subclass	NES COL15A1 MECOM ADGRA2 PTPRG HECW2 KANK3	7.91e-06	198	161	7	97ef7946ef11ac93318c1dd46b548dc01e5a6aba
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES COL15A1 MECOM PTPRG HECW2 KANK3 PLCB1	7.91e-06	198	161	7	e9e98c20ff7b3f3851db86381550ce7085e2db9e
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NES HECW2 KIAA1217 KANK3 PLCB1 NAV1 SMAD6	7.91e-06	198	161	7	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	metastatic_Brain-Endothelial_cells-Tumor_ECs\|metastatic_Brain / Location, Cell class and cell subclass	NES COL15A1 MECOM ADGRA2 PTPRG HECW2 KANK3	7.91e-06	198	161	7	5e274f29cc796dae7d64d6035e904816c25f9914
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO MECOM HID1 PTPRG KIAA1217 SYNE2 CTNND1	8.45e-06	200	161	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MECOM PTPRG SYNE2 PLCB1 TACC1 PKN3 SMAD6	8.45e-06	200	161	7	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	TRIO CHD4 ZFHX4 NAV1 KDM4B PRRC2B MAST3	8.45e-06	200	161	7	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MECOM SPECC1 PTPRG SYNE2 PLCB1 TACC1 PKN3	8.45e-06	200	161	7	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PCDHGA7 BICRA SPAG8 YJEFN3 RETREG3 SYT1	8.63e-06	132	161	6	9633653dba1edee47d915212fb6e68426da49de5
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYBPH GSX1 PCDHGA7 DUSP9 ZNF469	1.90e-05	90	161	5	3817a5b0235e632d976ea565175bdbebbd959bf0
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYBPH GSX1 PCDHGA7 DUSP9 ZNF469	1.90e-05	90	161	5	a528f5dcee1a356dea89ff2588d2e0f276f2d5fc
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RASSF2 KBTBD8 LRRK1 EDC4 SPECC1 NAV1	1.93e-05	152	161	6	0769857f25da2e6169420818e61d65e33b7277b1
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma_Heterologous_Type\|TCGA-Uterus / Sample_Type by Project: Shred V9	ZNF696 ANGPTL6 PPM1F TIGD5	2.50e-05	47	161	4	8e0bd9da3e18c7005d5a07d62f6dbc841ae5c675
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	AKAP6 COL15A1 SYNM NTRK3 ADGRA2 PLCB1	2.57e-05	160	161	6	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)\|Striatum / BrainAtlas - Mouse McCarroll V32	CACNA1F COL28A1 DUSP9 PERM1 SEBOX	2.59e-05	96	161	5	d98df92856840602a82d3f050bf0a1543445cac0
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-\|Striatum / BrainAtlas - Mouse McCarroll V32	CACNA1F COL28A1 DUSP9 PERM1 SEBOX	2.59e-05	96	161	5	bf62c29da66aa3eefdc59337dfb3cd0467f04f10
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	SZT2 SYNM ARID1A ZSCAN18 AKAP13 MGA	2.76e-05	162	161	6	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	PDE4D MECOM HID1 PTPRG KIAA1217 AKAP13	2.86e-05	163	161	6	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	3'_v3-bone_marrow-Mast-Mast_cell_lympho\|bone_marrow / Manually curated celltypes from each tissue	ATP6V0A1 MAP1A TRIO MS4A2 CSF2RB RAPGEF2	3.62e-05	170	161	6	4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPRC1 SAP30L FCER2 TMEM268 CTNND1 CCDC191	3.74e-05	171	161	6	23b3120706bb9c20b9214fe3760c6d7a84f1e749
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	SIN3B HECW2 KIAA1217 KANK3 PKN3 SMAD6	3.74e-05	171	161	6	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	Endothelial-B-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	SYNM ADGRA2 ZFHX4 PPM1F KANK3 SYT1	3.74e-05	171	161	6	07ff7059071da83da1d8f266a586573920d75b58
ToppCell	ASK428-Immune-B_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	SOX9 MUC16 HID1 LRRK1 MSH6 KDM4B	4.12e-05	174	161	6	b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYF6 NES SYNM ADGRA2 PLCB1 TACC1	4.53e-05	177	161	6	452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCell	metastatic_Brain-Endothelial_cells-Lymphatic_ECs\|metastatic_Brain / Location, Cell class and cell subclass	RSPH4A MAP1A NTRK3 ADGRA2 ZFHX4 KANK3	4.82e-05	179	161	6	56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 DLGAP1 PDE4D HECW1 SYNE2 TRPV4	5.13e-05	181	161	6	9542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 DLGAP1 PDE4D HECW1 SYNE2 TRPV4	5.13e-05	181	161	6	8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NES MECOM SPECC1 PTPRG PLCB1 TACC1	5.29e-05	182	161	6	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	NES MAP1A SYNM NTRK3 ADGRA2 NGEF	5.45e-05	183	161	6	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES COL15A1 MCM10 PPM1F HECW2 KANK3	5.62e-05	184	161	6	fa38d6a8709f520a027ad7e3ff783c84187ec467
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES SYNM PPM1F HECW2 KANK3 SMAD6	5.79e-05	185	161	6	512a195ebbae445afe3722a3943020080daf2f3c
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	HECW2 KIAA1217 KANK3 NAV1 PKN3 SMAD6	5.79e-05	185	161	6	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 MFHAS1 PTPRG SYNE2 PKHD1 PLCB1	5.96e-05	186	161	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL15A1 HID1 ADGRA2 PPM1F KANK3 PKN3	5.96e-05	186	161	6	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HID1 RFX8 PPM1F TRPV4 PKN3 SMAD6	6.14e-05	187	161	6	3827fa80e558b642f3e0036f5ee1a8b69f437e30
ToppCell	droplet-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HID1 RFX8 PPM1F TRPV4 PKN3 SMAD6	6.14e-05	187	161	6	1bf696eb03422ea507d3efe58dda1d442a65225d
ToppCell	droplet-Lung-3m-Endothelial-venous_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HID1 RFX8 PPM1F TRPV4 PKN3 SMAD6	6.14e-05	187	161	6	ebe4d1216cc0d4c079b413d5a5460cfd3a4af922
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL15A1 SZT2 ARMCX4 KANK3 NPRL3 PLCB1	6.14e-05	187	161	6	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL15A1 SZT2 ARMCX4 KANK3 NPRL3 PLCB1	6.14e-05	187	161	6	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPRG HECW2 KIAA1217 KANK3 PLCB1 SMAD6	6.33e-05	188	161	6	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLGAP1 COL15A1 PPM1F HECW2 KANK3 PLCB1	6.33e-05	188	161	6	0026c9479b30fb39daa91cfa220a88f9c9e65fe7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE4D HECW1 LRRK1 NGEF RAPGEF2 MAST3	6.33e-05	188	161	6	50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 MFHAS1 PTPRG SYNE2 PKHD1 PLCB1	6.33e-05	188	161	6	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	NES HECW2 KIAA1217 KANK3 PKN3 SMAD6	6.33e-05	188	161	6	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	AKAP6 NES SYNM NTRK3 SPECC1 PLCB1	6.33e-05	188	161	6	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D MECOM KIAA1217 PKHD1 PLCB1 TACC1	6.52e-05	189	161	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM LRRK1 PLCB1 NAV1 PKN3 SMAD6	6.52e-05	189	161	6	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 DLGAP1 PDE4D HECW1 SYNE2 PKHD1	6.52e-05	189	161	6	28b502611829e4a24caff2562545c7db97686099
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	PTPRG HECW2 KIAA1217 KANK3 PLCB1 SMAD6	6.71e-05	190	161	6	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	IFNGR1 PTPRG HECW2 KIAA1217 NAV1 SMAD6	6.71e-05	190	161	6	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM LRRK1 PLCB1 NAV1 PKN3 SMAD6	6.71e-05	190	161	6	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NES HECW2 KIAA1217 KANK3 PKN3 SMAD6	6.71e-05	190	161	6	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MECOM PTPRG HECW2 KIAA1217 PLCB1 SMAD6	6.71e-05	190	161	6	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Control-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	NES PTPRG HECW2 KIAA1217 KANK3 SMAD6	6.91e-05	191	161	6	c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MFHAS1 COL28A1 MECOM PTPRG PKHD1 PLCB1	6.91e-05	191	161	6	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	NES PTPRG HECW2 KIAA1217 KANK3 SMAD6	6.91e-05	191	161	6	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SOX9 COL15A1 DUSP9 ANGPTL6 NGEF TRPV4	6.91e-05	191	161	6	273c4a757292a9301de0eaeacdec91c9866be229
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NES MECOM PLCB1 SYT1 TACC1 PKN3	6.91e-05	191	161	6	04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NES MECOM PLCB1 SYT1 TACC1 PKN3	6.91e-05	191	161	6	db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO MFHAS1 COL28A1 MECOM PKHD1 PLCB1	6.91e-05	191	161	6	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	BNC2 COL15A1 MECOM PTPRG PLCB1 UGGT2	6.91e-05	191	161	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	ATP6V0A1 MFHAS1 BICRA PIEZO1 EBLN2 AAK1 RAD54L2 ADGRA2 SLC19A1 NCOA1 PACS2 KDM4B	1.14e-08	195	157	12	1144_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	BNC2 TRIO WDR70 ZFHX4 NCOA1 GIGYF2 AKAP13 RAPGEF2 MGA KDM4B	3.18e-07	171	157	10	7535_DN
Drug	0175029-0000 [211245-78-2]; Down 200; 1uM; MCF7; HT_HG-U133A	SYNM JADE2 KHNYN MSH6 SLC19A1 TMEM268 TACC1 ZBTB3 KDM4B SMAD6	7.98e-07	189	157	10	4716_DN
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	KAT5 JADE2 SAP30L MCM10 TSSC4 GTF3C4 MSH6 PLEKHM2 NCOA1 ZNF282	9.66e-07	193	157	10	7084_DN
Drug	C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	EBLN2 AAK1 MCM10 TRMU SLC19A1 PPM1F SOCS5 SUPT7L NCOA1 UGGT2	9.66e-07	193	157	10	865_DN
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	GRWD1 SLC43A1 APC THADA NPRL3 LRP3 UGGT2 MAPK7 ZNF282 PRRC2B	1.11e-06	196	157	10	6309_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BNC2 KAT5 JADE2 APC TSSC4 ARID1A PPM1F ZNF282 PRRC2B	4.18e-06	178	157	9	7245_DN
Drug	oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA	SOX9 TRIO EBLN2 MINK1 TRMU PPM1F SOCS5 LRP3 KDM4B	8.76e-06	195	157	9	863_DN
Drug	Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A	PIEZO1 ZNF217 PPM1F SOCS5 TMEM268 AKAP13 TACC1 PRRC2B SMAD6	9.13e-06	196	157	9	7139_DN
Drug	Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	KAT5 MAP1A MFHAS1 APC LRRK1 SPAG8 AKAP13 TADA2A MAST3	9.51e-06	197	157	9	5100_DN
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MINK1 DUSP9 APC ARID1A PPM1F PLCB1 AKAP13 TACC1 MAST3	9.51e-06	197	157	9	7484_UP
Drug	AH6809; Up 200; 1uM; PC3; HT_HG-U133A	MFHAS1 MINK1 APC PLEKHM2 ZNF358 SUPT7L PLCB1 PACS2 KDM4B	1.03e-05	199	157	9	7075_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 GRWD1 JADE2 PPRC1 ARID1A SLC19A1 TMEM268 ZNF282	2.24e-05	168	157	8	6820_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A TRMU SLC19A1 ZNF282	2.65e-05	172	157	8	7179_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A SLC19A1 TMEM268 ZNF282	2.76e-05	173	157	8	3243_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A SLC19A1 TMEM268 ZNF282	2.88e-05	174	157	8	5693_DN
Drug	Alprostadil [745-65-3]; Down 200; 11.2uM; HL60; HT_HG-U133A	COL15A1 PIEZO1 SLC43A1 LRRK1 ADGRA2 FCER2 SLC19A1 LRP3	3.00e-05	175	157	8	2938_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A SLC19A1 TMEM268 ZNF282	3.12e-05	176	157	8	6784_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 ARID1A SLC19A1 TMEM268 ZNF282 PRRC2B	3.66e-05	180	157	8	5511_DN
Drug	GW8510; Down 200; 10uM; PC3; HT_HG-U133A	SOX9 ZNF217 ARID1A MSH6 GSPT2 TSPYL5 RAPGEF2 MGA	3.96e-05	182	157	8	7085_DN
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A	KAT5 GRWD1 JADE2 PPRC1 LRRK1 ZNF358 TMEM268 ZNF282	4.12e-05	183	157	8	4527_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	SOX9 BNC2 TRIO APC RAD54L2 AKAP13 RAPGEF2 KDM4B	5.18e-05	189	157	8	6649_DN
Drug	9-methyluric acid	ATP6V0A1 SYNM ZNF185 SYNE2	5.92e-05	31	157	4	CID000108714
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SOX9 GRWD1 TRMU PLEKHM2 SLC19A1 PPM1F NPRL3 PLCB1	6.00e-05	193	157	8	1667_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	NES PPRC1 PLEKHM2 SLC19A1 PLCB1 LRP3 MAST3 YIPF6	6.00e-05	193	157	8	1664_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SOX9 TRIO MINK1 RAD54L2 SLC19A1 MAPK7 MAST3 YIPF6	6.00e-05	193	157	8	5239_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	GRWD1 TRIO AAK1 APC TSSC4 ARID1A SLC19A1 SOCS5	6.45e-05	195	157	8	6927_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	MAP1A MINK1 LRRK1 RAD54L2 SPAG8 NPRL3 LRP3 MAPK7	6.45e-05	195	157	8	4199_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	HECW1 MAP1A SZT2 AAK1 APC SPAG8 TRPV4 MAPK7	6.45e-05	195	157	8	5576_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; HL60; HT_HG-U133A	MYBPH PIEZO1 APC LRRK1 SPAG8 ARID1A SLC19A1 PACS2	6.45e-05	195	157	8	2446_DN
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A	KAT5 EDC4 ARID1A TRMU LRP3 NCOA1 AKAP13 KDM4B	6.45e-05	195	157	8	1290_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A	TRIO SZT2 BICRA MINK1 APC MECOM TRMU PLEKHM2	6.69e-05	196	157	8	7360_DN
Drug	Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A	SIN3B GRWD1 JADE2 PIEZO1 RAD54L2 THADA TMEM268 MAST3	6.69e-05	196	157	8	7143_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	SOX9 GRWD1 TRIO JADE2 GTF3C4 IFNGR1 NPRL3 ZNF282	6.69e-05	196	157	8	1054_DN
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; HL60; HT_HG-U133A	ATP6V0A1 ZNF185 LRRK1 NPRL3 PLCB1 NCOA1 CTNND1 KDM4B	6.69e-05	196	157	8	2160_DN
Drug	Pizotifen malate [5189-11-7]; Down 200; 9.4uM; HL60; HT_HG-U133A	MINK1 ZNF185 APC TSSC4 TADA2A CTNND1 MAPK7 MAST3	6.69e-05	196	157	8	3134_DN
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A	ATP6V0A1 APC TRMU THADA SLC19A1 PPM1F NCOA1 TACC1	6.69e-05	196	157	8	7329_DN
Drug	Iobenguane sulfate; Down 200; 10.8uM; HL60; HG-U133A	MAP1A PPRC1 RIOK3 ZNF217 MCM10 AKAP13 RAPGEF2 PRRC2B	6.69e-05	196	157	8	1729_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	JADE2 RAD54L2 SLC19A1 AGA PLCB1 ZNF282 KDM4B MAST3	6.69e-05	196	157	8	7552_UP
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A	ATP6V0A1 COL15A1 BICRA TADA2A RAPGEF2 ZBTB3 KDM4B MAST3	6.93e-05	197	157	8	2975_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	NES ZNF696 EDC4 TRMU THADA SOCS5 NCOA1 TACC1	6.93e-05	197	157	8	5514_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	TRIO BICRA APC SPAG8 ADGRA2 ZFHX4 SUPT7L PLCB1	6.93e-05	197	157	8	7177_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A	NES APC MECOM TSSC4 TRMU MSH6 SLC19A1 NPRL3	6.93e-05	197	157	8	6975_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; HL60; HG-U133A	ATP6V0A1 KAT5 PIEZO1 RIOK3 EDC4 RETREG3 MSH6 LRP3	6.93e-05	197	157	8	1406_DN
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A	PIEZO1 EBLN2 MINK1 LRRK1 SLC19A1 PLCB1 SYT1 KDM4B	6.93e-05	197	157	8	4277_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; HL60; HG-U133A	MAP1A SZT2 APC SOCS5 NPRL3 TACC1 PRRC2B RAD21	7.18e-05	198	157	8	1428_DN
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A	HECW1 MAP1A SZT2 RASSF2 SPAG8 ADGRA2 NCAN MAPK7	7.18e-05	198	157	8	4839_UP
Drug	Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A	APC RAD54L2 PLEKHM2 SLC19A1 SUPT7L PLCB1 SYT1 MAST3	7.18e-05	198	157	8	5258_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	EBLN2 MINK1 APC ARID1A PPM1F PLCB1 TACC1 MAPK7	7.18e-05	198	157	8	6080_DN
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A	TRIO PPRC1 APC CHD4 PPM1F NCOA1 ZNF282 MAST3	7.44e-05	199	157	8	2806_DN
Drug	tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A	NES DLGAP1 LRRK1 IFNGR1 ZNF358 NCAN SYNE2 PLCB1	7.44e-05	199	157	8	143_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	MAP1A TRIO APC LRRK1 RAD54L2 SPAG8 MAPK7 KDM4B	7.44e-05	199	157	8	6624_DN
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; HL60; HG-U133A	MINK1 AAK1 ZNF696 THADA SLC19A1 RAPGEF2 SMAD6 RAD21	7.44e-05	199	157	8	1973_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; HL60; HT_HG-U133A	AAK1 CHD4 TSSC4 ADGRA2 RETREG3 NCOA1 KDM4B PRRC2B	7.70e-05	200	157	8	1278_DN
Drug	Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	MINK1 SAP30L RAD54L2 TMEM268 NPRL3 NCOA1 PACS2 PRRC2B	7.70e-05	200	157	8	5782_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A	GRWD1 TRIO SYNM TRMU PLEKHM2 PPM1F NCOA1 SMAD6	7.70e-05	200	157	8	7002_DN
Drug	TEI-6472	MS4A2 FCER2	1.41e-04	3	157	2	CID006440732
Drug	3-fluoroisonicotinic acid	MS4A2 FCER2	1.41e-04	3	157	2	CID000345361
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A SLC19A1 TMEM268	1.76e-04	169	157	7	5572_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 ARID1A SLC19A1 TMEM268 TADA2A	1.96e-04	172	157	7	5903_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BNC2 KAT5 JADE2 PPRC1 ARID1A PLEKHM2 SLC19A1	2.03e-04	173	157	7	4665_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	BNC2 KAT5 JADE2 PPRC1 ARID1A SLC19A1 RAD21	2.10e-04	174	157	7	5940_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A TADA2A ZBTB3	2.18e-04	175	157	7	3787_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	KAT5 JADE2 PPRC1 ARID1A SLC19A1 TMEM268 ZNF282	2.18e-04	175	157	7	1014_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 GRWD1 JADE2 ARID1A SLC19A1 EIF2B5 TMEM268	2.25e-04	176	157	7	6932_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	KAT5 JADE2 PPRC1 ARID1A SLC19A1 TMEM268 PRRC2B	2.33e-04	177	157	7	873_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A SLC19A1 TMEM268	2.33e-04	177	157	7	6551_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 GRWD1 JADE2 PPRC1 ARID1A TMEM268 ZNF282	2.33e-04	177	157	7	5308_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	SOX9 BNC2 APC MSH6 NCOA1 SYT1 TADA2A	2.33e-04	177	157	7	4652_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A MSH6 SLC19A1	2.50e-04	179	157	7	6910_DN
Drug	GW8510; Down 200; 10uM; PC3; HT_HG-U133A	SOX9 ZNF217 MSH6 GSPT2 TSPYL5 RAPGEF2 MGA	2.76e-04	182	157	7	7067_DN
Drug	DIBADL	MS4A2 FCER2	2.81e-04	4	157	2	CID000194129
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	KAT5 JADE2 PPRC1 TSSC4 ARID1A SLC19A1 TMEM268	2.86e-04	183	157	7	3510_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	WDR70 MSH6 SYT1 GIGYF2 AKAP13 RAPGEF2 MGA	2.86e-04	183	157	7	7498_DN
Drug	k143	APC NCOA1 TP53BP2	2.87e-04	19	157	3	CID000590836
Drug	Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A	NES GRWD1 MCM10 TRMU MSH6 SLC19A1 PPM1F	3.05e-04	185	157	7	5439_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	GRWD1 MCM10 SLC19A1 PPM1F TACC1 MAST3 SMAD6	3.15e-04	186	157	7	916_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	GRWD1 PPRC1 MSH6 PPM1F NCOA1 TACC1 SMAD6	3.47e-04	189	157	7	1643_DN
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	SOX9 NES GRWD1 PPRC1 PPM1F KDM4B YIPF6	3.47e-04	189	157	7	6997_DN
Drug	CP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A	SZT2 AAK1 PLCB1 SYT1 AKAP13 ZBTB3 PRRC2B	3.47e-04	189	157	7	7537_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	MAP1A TRIO EBLN2 MINK1 APC LRRK1 AKAP13	3.47e-04	189	157	7	5084_DN
Drug	16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	PDE4D SZT2 MFHAS1 MINK1 ZNF358 SYT1 TADA2A	3.59e-04	190	157	7	7546_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	KAT5 JADE2 SLC43A1 TRMU THADA SLC19A1 ZBTB3	3.59e-04	190	157	7	1306_DN
Drug	Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A	SOX9 APC ZNF696 ARID1A MSH6 PLCB1 ZBTB3	3.59e-04	190	157	7	6680_DN
Drug	0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A	SYNM MCM10 TRMU MSH6 SLC19A1 LRP3 MAST3	3.70e-04	191	157	7	6900_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	KAT5 GRWD1 JADE2 TRMU THADA SLC19A1 AGA	3.82e-04	192	157	7	1400_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	PPRC1 MINK1 EDC4 ARID1A PLEKHM2 PPM1F SMAD6	3.82e-04	192	157	7	5222_DN
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A	ATP6V0A1 MINK1 SPAG8 SLC19A1 SUPT7L PLCB1 MAST3	3.82e-04	192	157	7	6013_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 ARID1A MSH6 PPM1F SOCS5 TACC1 SMAD6	3.94e-04	193	157	7	1644_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A	NTRK3 MINK1 CASP4 ADGRA2 PLEKHM2 ZNF358 AKAP13	3.94e-04	193	157	7	4795_UP
Drug	LY 294002; Down 200; 10uM; PC3; HT_HG-U133A	GRWD1 MFHAS1 PPRC1 MCM10 SLC19A1 MAPK7 KDM4B	3.94e-04	193	157	7	4460_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	EBLN2 MINK1 SPAG8 PPM1F NCOA1 TACC1 KDM4B	3.94e-04	193	157	7	6997_UP
Drug	Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A	MAP1A CASP4 MECOM HUWE1 SPAG8 CSF2RB MAST3	3.94e-04	193	157	7	4118_UP
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SOX9 APC SPAG8 ADGRA2 PLCB1 RAPGEF2 MAPK7	3.94e-04	193	157	7	7187_UP
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A	KAT5 MINK1 RAD54L2 SPAG8 PPM1F PLCB1 TADA2A	3.94e-04	193	157	7	5608_DN
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	ATP6V0A1 GRWD1 MINK1 PPM1F TACC1 MAPK7 MAST3	4.07e-04	194	157	7	6070_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A	TRIO SLC43A1 APC IFNGR1 PLEKHM2 SLC19A1 SOCS5	4.07e-04	194	157	7	1947_DN
Drug	Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A	NES EBLN2 NPRL3 LRP3 NCOA1 TACC1 KDM4B	4.07e-04	194	157	7	7196_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	MAP1A EDC4 RAD54L2 MCM10 ZNF358 LRP3 MAPK7	4.07e-04	194	157	7	4325_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NES MINK1 DUSP9 RAD54L2 ZNF358 NCOA1 MAPK7	4.19e-04	195	157	7	3850_DN
Disease	hair colour measurement	BNC2 SPIRE2 PDE4D NYAP2 PIEZO1 KBTBD8 ARID1A ZNF469 THADA KMT2D ZNF358 SYNE2 NGEF PKHD1 AKAP13 TACC1 HERC2	1.95e-08	615	151	17	EFO_0007822
Disease	reticulocyte count	BNC2 SPIRE2 NYAP2 KAT5 PIEZO1 KBTBD8 PROCA1 RIOK3 ZNF217 SPECC1 ZNF469 THADA SLC19A1 KANK3 SYNE2 PKD1 NPRL3 PLCB1	7.13e-06	1045	151	18	EFO_0007986
Disease	reticulocyte measurement	BNC2 SPIRE2 NYAP2 KAT5 PIEZO1 KBTBD8 RIOK3 ZNF217 SPECC1 TRMU ZNF469 SLC19A1 KANK3 SYNE2 NPRL3 PLCB1 AKAP13 CTNND1	7.91e-06	1053	151	18	EFO_0010700
Disease	urate measurement	BNC2 NYAP2 PCNX3 MFHAS1 AAK1 MECOM ARID1A CACNA2D4 PKHD1 NAV1 SYT1 UGGT2 AKAP13 KDM4B PRRC2B MAST3	1.51e-05	895	151	16	EFO_0004531
Disease	thyroid stimulating hormone measurement	SOX9 PDE4D NYAP2 AAK1 THAP4 ANGPTL6 THADA KIAA1217 SMAD6	4.57e-05	323	151	9	EFO_0004748
Disease	age at menarche	DLGAP1 PDE4D JADE2 AAK1 ARID1A MSH6 ZFHX4 PTPRG PPM1F PLCB1 KDM4B MAST3	5.87e-05	594	151	12	EFO_0004703
Disease	cortical thickness	AKAP6 BNC2 SPIRE2 NYAP2 MECOM SPECC1 ADGRA2 ZNF469 THADA UBN1 SLC19A1 PKD1 PKHD1 NAV1 SYT1 TACC1 KDM4B	5.90e-05	1113	151	17	EFO_0004840
Disease	mean reticulocyte volume	DLGAP1 SPIRE2 NYAP2 PPRC1 PIEZO1 CHD4 ZNF217 SPECC1 ZNF469 THADA SLC19A1 KIAA1217 NPRL3 AKAP13	6.56e-05	799	151	14	EFO_0010701
Disease	T-Cell Lymphoma	ARID1A KMT2D MGA	7.01e-05	16	151	3	C0079772
Disease	uric acid measurement	NYAP2 PCNX3 DUSP9 KBTBD8 AAK1 MECOM ARID1A NAV1 SYT1 AKAP13 KDM4B PRRC2B	7.56e-05	610	151	12	EFO_0004761
Disease	sphingomyelin 14:0 measurement	PDE4D THADA SYNE2	8.48e-05	17	151	3	EFO_0010390
Disease	monocyte percentage of leukocytes	NYAP2 JADE2 PIEZO1 MECOM ARHGAP30 ARID1A THADA FCER2 PLCB1 NCOA1 AKAP13 TADA2A KDM4B	1.04e-04	731	151	13	EFO_0007989
Disease	blood urea nitrogen measurement	DLGAP1 DUSP9 KBTBD8 MECOM MIER1 TRMU PKHD1 PLCB1 UGGT2 AKAP13	1.18e-04	452	151	10	EFO_0004741
Disease	Calcium channel blocker use measurement	NYAP2 NEIL2 MFHAS1 MECOM TTBK1 NPRL3 PLCB1	1.19e-04	213	151	7	EFO_0009930
Disease	cortical surface area measurement	BNC2 SPIRE2 NYAP2 PCNX3 MFHAS1 KHNYN APC PERM1 MECOM ADGRA2 SNAP29 ZNF469 THADA PKD1 PKHD1 NAV1 SYT1 TACC1	1.87e-04	1345	151	18	EFO_0010736
Disease	obsolete_red blood cell distribution width	NYAP2 KAT5 CARMIL2 PIEZO1 KHNYN KBTBD8 MECOM CHD4 ZNF217 TRMU SLC19A1 HECW2 KIAA1217 SYNE2 AKAP13 TIGD5 MAST3 SMAD6	1.90e-04	1347	151	18	EFO_0005192
Disease	chronic mountain sickness	AEBP2 TACC1	2.58e-04	5	151	2	EFO_0010143
Disease	Turcot syndrome (disorder)	APC MSH6	2.58e-04	5	151	2	C0265325
Disease	autosomal recessive osteopetrosis 1 (implicated_via_orthology)	ATP6V0A1 CCDC154	2.58e-04	5	151	2	DOID:0110942 (implicated_via_orthology)
Disease	polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement	DLGAP1 TACC1	2.58e-04	5	151	2	EFO_0007961, EFO_0007962, EFO_0007964
Disease	neutrophil count	NES BNC2 JADE2 NEIL2 MECOM RIOK3 ARID1A THADA MS4A2 FCER2 PKD1 PLCB1 NCOA1 SYT1 AKAP13 ZNF282 PKN3 KDM4B	2.60e-04	1382	151	18	EFO_0004833
Disease	mean arterial pressure	NYAP2 PCNX3 SZT2 MECOM THADA TTBK1 KIAA1217 PKHD1 NPRL3 KDM4B	2.62e-04	499	151	10	EFO_0006340
Disease	testosterone measurement	DLGAP1 NYAP2 KAT5 MAP1A JADE2 MECOM ARID1A MSH6 THADA TTBK1 ZFHX4 PTPRG SYNE2 RTL9 PLCB1 NCOA1 PKN3	2.97e-04	1275	151	17	EFO_0004908
Disease	Agents acting on the renin-angiotensin system use measurement	NYAP2 KAT5 MFHAS1 MECOM ARID1A PKHD1 NPRL3 PLCB1	3.46e-04	335	151	8	EFO_0009931
Disease	hemoglobin A1 measurement	NYAP2 PIEZO1 DUSP9 SPECC1 THADA SLC19A1 SYNE2 PLCB1 AKAP13 MGA	3.63e-04	520	151	10	EFO_0007629
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	KANK3 SYNE2	3.85e-04	6	151	2	EFO_0800611
Disease	monocyte count	AAMP NYAP2 SZT2 JADE2 PIEZO1 MECOM ARHGAP30 MIER1 SNAP29 THADA PKD1 PLCB1 NCOA1 SYT1 AKAP13 TADA2A KDM4B	4.42e-04	1320	151	17	EFO_0005091
Disease	Endometrial Carcinoma	CHD4 ARID1A MSH6 RAD21	5.17e-04	72	151	4	C0476089
Disease	stomach cancer (is_implicated_in)	NTRK3 APC ARID1A KDM4B	5.17e-04	72	151	4	DOID:10534 (is_implicated_in)
Disease	mean arterial pressure, unipolar depression	PCNX3 MECOM NPRL3	5.84e-04	32	151	3	EFO_0003761, EFO_0006340
Disease	reaction time measurement	AKAP6 BNC2 APC CASP4 MECOM CACNA2D4 KMT2D NGEF PKHD1 NCOA1 GIGYF2	5.99e-04	658	151	11	EFO_0008393
Disease	Schizophrenia	CACNA1F DLGAP1 PDE4D NTRK3 APC CASP4 CHD4 SNAP29 CSF2RB AGA NCAN PLCB1 NAV1	6.37e-04	883	151	13	C0036341
Disease	Adenocarcinoma of lung (disorder)	GRWD1 NTRK3 APC MSH6 SLC19A1 EIF2B5	6.93e-04	206	151	6	C0152013
Disease	Immediate hypersensitivity	MS4A2 FCER2	7.14e-04	8	151	2	C0020523
Disease	ovarian cancer (implicated_via_orthology)	APC MSH6	7.14e-04	8	151	2	DOID:2394 (implicated_via_orthology)
Disease	Bladder Neoplasm	ARID1A YJEFN3 KMT2D SLC19A1 NCAN	7.87e-04	140	151	5	C0005695
Disease	Cleft Palate	SOX9 BNC2 SLC19A1 CTNND1	8.08e-04	81	151	4	C0008925
Disease	Malignant neoplasm of urinary bladder	ARID1A YJEFN3 KMT2D SLC19A1 NCAN	8.12e-04	141	151	5	C0005684
Disease	endometrial cancer (is_implicated_in)	APC MSH6 RAD21	8.29e-04	36	151	3	DOID:1380 (is_implicated_in)
Disease	obesity (implicated_via_orthology)	KAT5 ANGPTL6 THADA ZFHX4 PLCB1 NCOA1	8.65e-04	215	151	6	DOID:9970 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	AAMP NYAP2 MAP1A PCNX3 BICRA PERM1 ARID1A THADA PKD1 PKHD1 AKAP13 PKN3 MAST3	8.74e-04	914	151	13	EFO_0004532
Disease	Lynch Syndrome	APC MSH6	9.15e-04	9	151	2	C4552100
Disease	Cancer of Nasopharynx	RASSF2 MECOM	9.15e-04	9	151	2	C0238301
Disease	Nasopharyngeal Neoplasms	RASSF2 MECOM	9.15e-04	9	151	2	C0027439
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	NYAP2 KAT5 ARID1A KANK3 NCAN SYNE2	1.07e-03	224	151	6	EFO_0004530, EFO_0008317
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A NCAN	1.14e-03	10	151	2	EFO_0004530, EFO_0600007
Disease	Malignant neoplasm of breast	AKAP6 KBTBD8 MECOM ARID1A MSH6 KMT2D PPM1F SYNE2 PLCB1 NCOA1 HERC2 ZBTB3 DEK TP53BP2	1.28e-03	1074	151	14	C0006142
Disease	anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine	MCM10 TADA2A	1.39e-03	11	151	2	EFO_0803358, EFO_0803362
Disease	intracranial aneurysm (is_implicated_in)	KMT2D PKD1	1.66e-03	12	151	2	DOID:10941 (is_implicated_in)
Disease	sexual dimorphism measurement	NYAP2 KAT5 WDR70 APC RIOK3 RAD54L2 ACSS2 ARID1A UBN1 PTPRG KANK3 PKD1 NPRL3 MGA	1.68e-03	1106	151	14	EFO_0021796
Disease	Connective Tissue Diseases	ZNF469 PKD1	1.96e-03	13	151	2	C0009782
Disease	suntan	BNC2 SPIRE2 KIAA1217 HERC2	1.97e-03	103	151	4	EFO_0004279
Disease	actinic keratosis	BNC2 HERC2	2.27e-03	14	151	2	EFO_0002496
Disease	lymphocyte percentage of leukocytes	NYAP2 KHNYN MINK1 LRRK1 ARID1A MIER1 TRMU THADA PLCB1 KDM4B	2.31e-03	665	151	10	EFO_0007993
Disease	estradiol measurement	RFX8 PLCB1 NAV1 TSPYL5	2.50e-03	110	151	4	EFO_0004697
Disease	cardiovascular disease	NYAP2 MECOM THADA UBN1 PKHD1 NPRL3 PLCB1 NAV1	2.52e-03	457	151	8	EFO_0000319
Disease	Replication Error Phenotype	ARID1A MSH6	2.61e-03	15	151	2	C1721098
Disease	Microsatellite Instability	ARID1A MSH6	2.61e-03	15	151	2	C0920269
Disease	neuroticism measurement, cognitive function measurement	JADE2 APC RIOK3 ARID1A TTBK1 KIAA1217 NAV1 SYT1 MAST3	2.63e-03	566	151	9	EFO_0007660, EFO_0008354
Disease	IGFBP-3 measurement	DLGAP1 MFHAS1 PKN3	2.69e-03	54	151	3	EFO_0004626
Disease	clonal hematopoiesis mutation measurement	MSH6 PLCB1 HERC2	2.84e-03	55	151	3	EFO_0020949
Disease	antihyperlipidemic drug use measurement	BNC2 ARID1A TRMU RTL9	2.93e-03	115	151	4	EFO_0803367
Disease	response to triptolide, cytotoxicity measurement	ADGRA2 TP53BP2	2.98e-03	16	151	2	EFO_0006952, EFO_0007662
Disease	preeclampsia, hypertension, pregnancy-induced	MECOM NPRL3	2.98e-03	16	151	2	EFO_0000668, MONDO_0024664
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKD1 PKHD1	2.98e-03	16	151	2	DOID:0110861 (implicated_via_orthology)
Disease	sphingomyelin measurement	NYAP2 MINK1 KANK3 NCAN SOCS5 SYNE2	3.16e-03	278	151	6	EFO_0010118
Disease	free androgen index	NYAP2 ARID1A ZNF469 THADA ZFHX4 PTPRG PKN3	3.23e-03	374	151	7	EFO_0007005
Disease	myeloid white cell count	PIEZO1 MECOM RIOK3 LRRK1 FAM200A THADA PKD1 PLCB1 SYT1 TADA2A ZNF282 PKN3	3.26e-03	937	151	12	EFO_0007988
Disease	Endometrial Neoplasms	CHD4 ARID1A MSH6	3.30e-03	58	151	3	C0014170
Disease	Night blindness, congenital stationary	CACNA1F CACNA2D4	3.36e-03	17	151	2	C0339535
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO KDM4B	3.36e-03	17	151	2	DOID:0060307 (is_implicated_in)
Disease	oral motor function measurement	DLGAP1 GSX1	3.36e-03	17	151	2	EFO_0021793
Disease	Colorectal Carcinoma	AKAP6 RASSF2 APC ZNF217 ARID1A MSH6 MYLK3 SLC19A1 PPM1F PKHD1	3.40e-03	702	151	10	C0009402
Disease	prostate carcinoma, type 2 diabetes mellitus	AKAP6 NYAP2 THADA	3.46e-03	59	151	3	EFO_0001663, MONDO_0005148
Disease	colorectal cancer (is_implicated_in)	NTRK3 APC CHD4 KDM4B	3.52e-03	121	151	4	DOID:9256 (is_implicated_in)
Disease	Malignant neoplasm of endometrium	MSH6 RAD21	3.77e-03	18	151	2	C0007103
Disease	Myeloid Leukemia	MECOM RAD21	3.77e-03	18	151	2	C0023470
Disease	Leukemia, Monocytic, Chronic	MECOM RAD21	3.77e-03	18	151	2	C0023466
Disease	Carcinoma in situ of endometrium	MSH6 RAD21	3.77e-03	18	151	2	C0346191
Disease	triglycerides in small VLDL measurement	NYAP2 ARID1A KANK3	3.81e-03	61	151	3	EFO_0022145
Disease	response to opioid	DLGAP1 MUC16 CACNA2D4	3.81e-03	61	151	3	EFO_0008541
Disease	oral squamous cell carcinoma (is_marker_for)	KMT2D CTNND1 RAD21	4.17e-03	63	151	3	DOID:0050866 (is_marker_for)
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	NYAP2 KAT5 MINK1 SYNE2	4.19e-03	127	151	4	EFO_0008595, EFO_0020947
Disease	triglycerides in small LDL measurement	NYAP2 ARID1A KANK3	4.55e-03	65	151	3	EFO_0022323
Disease	vital capacity	BNC2 NYAP2 JADE2 PIEZO1 WDR70 MECOM RIOK3 IFNGR1 RTL9 PLCB1 NCOA1 SYT1 KDM4B SMAD6	4.56e-03	1236	151	14	EFO_0004312
Disease	Prostatic Neoplasms	PDE4D COL15A1 JADE2 APC ARID1A KMT2D NCOA1 AKAP13 MGA	4.57e-03	616	151	9	C0033578
Disease	Malignant neoplasm of prostate	PDE4D COL15A1 JADE2 APC ARID1A KMT2D NCOA1 AKAP13 MGA	4.57e-03	616	151	9	C0376358
Disease	age at menopause	NYAP2 ADGRA2 MSH6 MYLK3 ZFHX4 MGA	4.73e-03	302	151	6	EFO_0004704
Disease	breast carcinoma (is_marker_for)	MSH6 KMT2D NCOA1	4.75e-03	66	151	3	DOID:3459 (is_marker_for)
Disease	very low density lipoprotein particle size measurement	NYAP2 KAT5 ARID1A NCAN	4.93e-03	133	151	4	EFO_0008594
Disease	ovarian neoplasm	BNC2 MUC16 MECOM MSH6	5.06e-03	134	151	4	C0919267

Protein segments in the cluster

Peptide	Gene	Start	Entry
DAGPGLDPDMVTSTQ	PTPRG	661	P23470
SPPDALQDEAMTEGS	TACC1	186	O75410
SATYSELEDPGEMSP	MS4A2	226	Q01362
GGEAETMSEPSPESA	AEBP2	76	Q6ZN18
MESESESGAAADTPP	AAMP	1	Q13685
DLLPMTDPFGSTSDA	AAK1	806	Q2M2I8
GEPMLTPSEGSDTSA	ADGRA2	1246	Q96PE1
PMGLDVREDASSPAG	BNC2	926	Q6ZN30
NMEAGPPESGESTDA	CASP4	91	P49662
SDGDIMDSSTEAPPI	CARMIL2	1246	Q6F5E8
GDSGPDSSDMVPAAE	CT47B1	36	P0C2W7
GESLPMGSTPEEATG	AKAP13	1306	Q12802
NVDGTSVSPGDTEPM	SPECC1	211	Q5M775
MGDEDSGDSDTSPKP	DLGAP1	351	O14490
MSDESASGSDPDLDP	RAD54L2	1	Q9Y4B4
AELGMGDSTSQSPPI	ACSS2	256	Q9NR19
MSELADSGPSGASAP	CCDC154	1	A6NI56
MTPESRDTTDLSPGG	FAM200A	1	Q8TCP9
PEAEAMPTSESEGGS	ARMCX4	1066	Q5H9R4
SGEPEGPGEDSVSMR	TP53BP2	876	Q13625
ALPTDGSTGMELAPR	PCDHGA7	566	Q9Y5G6
PEGDQMPSSTDSRGL	RASSF2	116	P50749
EDDNVSMGGPDSPDS	RAD21	266	O60216
GEIRDSSASTMGAPP	RIMKLA	356	Q8IXN7
FGSSAPEGLEPDSMA	EDC4	756	Q6P2E9
PEGLEPDSMASAASA	EDC4	761	Q6P2E9
LEEMPDADGVASTPS	MECOM	26	Q03112
SKVSSPAPMEGGEEE	ARID1A	1751	O14497
GDLGSPSDDEDMPGS	HECW2	346	Q9P2P5
MSESEGGKDTTPEPS	CACNA1F	1	O60840
AGGAPQSSMSESPDV	MAPK7	696	Q13164
SMTPLETSAPGEESE	MUC16	436	Q8WXI7
SGELDPGMEPAAHSL	MAP1A	2286	P78559
MADSSPALSLREGGP	LYSMD2	1	Q8IV50
FDLDEEMGPPGSSPT	NEIL2	56	Q969S2
PMEAESGDTSSEGPA	GRWD1	16	Q9BQ67
DDMAEKSGSETPDGP	MGA	1406	Q8IWI9
TSGEGKAEGESSPPM	MFHAS1	756	Q9Y4C4
PSSLDAGPDTVVIGM	NTRK3	491	Q16288
GMATESPSDSPEDGP	TRMU	401	O75648
PALTATESDGTPLME	LRRK1	1146	Q38SD2
TDDGAVVSPDLGDMS	HERC2	2356	O95714
NLMESGSGEPRSEAP	HECW1	371	Q76N89
DSSDGIPSAPRMTGS	KAT5	201	Q92993
PSLEDGSDAFMSPQD	SLC43A1	266	O75387
QSMDSEEPDSRGGSP	EIF2B5	531	Q13144
ASPSSTMLGEGSQPD	JADE2	116	Q9NQC1
DQVDMESPGSAPSGD	GSPT2	16	Q8IYD1
CLDSSAPESGTPMGA	PCNX3	1996	Q9H6A9
DQMPPEAGSDSSGEE	MYF6	46	P23409
MPPGAEAGSVVLDDS	MYLK3	476	Q32MK0
DNGTSAGRSPLDPMT	PDE4D	156	Q08499
QPSSPGDDAMDRSGL	EBLN2	56	Q6P2I7
PSMDNSSAELLPSGD	NPRL3	461	Q12980
PASEGSAESMGPDSR	FCER2	291	P06734
SAESMGPDSRPDPDG	FCER2	296	P06734
EDDDELPMSPSSSGK	GSX1	241	Q9H4S2
DSMSCGLDSEGATPP	DUSP9	181	Q99956
SEPAMGESAAGAEPG	NES	1086	P48681
SPMELTGPEDGAASS	KDM4B	566	O94953
PAPLMDTGSTRAAGD	LRP3	651	O75074
GSEFPRLEGAPATMT	MCM10	611	Q7L590
SSLSQMGSPAGDPEE	NYAP2	226	Q9P242
EEGEASLPSPAMTLS	KIAA1191	71	Q96A73
SGPDMEDDDSVLSTP	PACS2	301	Q86VP3
GMTSESDSIGLTPGE	MSH6	661	P52701
GDTLAPMETDEPTAS	HUWE1	1016	Q7Z6Z7
GIPSSDPASDAMDPF	KBTBD8	16	Q8NFY9
PMSSGDTEDPGVASG	CSF2RB	696	P32927
FGMSGEELSESTPEP	COL28A1	1001	Q2UY09
GAPGMGSVSTEPDDE	GIGYF2	471	Q6Y7W6
EGPESAGEPMVVTAS	CACNA2D4	821	Q7Z3S7
MSASAPAAEGEGTPT	DEK	1	P35659
SGISLPEEATAMVGP	CCDC191	451	Q8NCU4
GSTSDTSRMLDPAPE	ANGPTL6	211	Q8NI99
ITADDGSGGPLMSPL	MAST3	906	O60307
GGSPDELGETTLDAM	AGA	76	P20933
APSLTQESSPGSMDG	KANK3	421	Q6NY19
APPSDGRESLDTGSM	KHNYN	226	O15037
SAASSLDADEDGPMP	BICRA	1276	Q9NZM4
GSPSPCSAGSEEEDM	CHD4	6	Q14839
ATMAPERAVTSGPGD	COL15A1	491	P39059
EMEAVVSEPSAGAPG	PERM1	471	Q5SV97
GSSRGSGVEMSLPDP	PPRC1	191	Q5VV67
ASPDLGTSMATGTPD	PROCA1	196	Q8NCQ7
VAMGPDGLPVDASSV	CTNND1	156	O60716
RAEMGTADLGPSSVP	IFNGR1	16	P15260
MAEPSVESSSPGGSA	MIER1	1	Q8N108
DMGDGTVLSGPEATV	PKD1	1246	P98161
PMASGAEETPGFLDT	PPM1F	11	P49593
MKISSLEASGSPEPG	PKN3	161	Q6P5Z2
SLPGTRASGSPEDLM	ARHGAP30	231	Q7Z6I6
GSPSLGRDSPDTMLA	PLEKHM2	356	Q8IWE5
DTMLASPQEEGEGPS	PLEKHM2	366	Q8IWE5
EGEPSSIMNVPGEST	MINK1	336	Q8N4C8
DTDLSPMDGISTCGP	NAV1	1401	Q8NEY1
SGGIPTPLMSDLDSG	RTL9	291	Q8NET4
APGGSEVAPSMLEIT	RSPH4A	196	Q5TD94
AAELPALDMGGTSDP	SYT1	166	P21579
GPFSSSMEEGAEPRE	SZT2	1366	Q5T011
SPEGLIPMDTDSESA	THADA	971	Q6YHU6
SEFMEPSSDPSLLGE	SPAG8	81	Q99932
TAPGEFSDASMSPDA	SMAD6	311	O43541
PKLAPGMTEISGDSS	SOCS5	301	O75159
MASSPELPTEDEQGS	SYNE2	1	Q8WXH0
GSPEPGPAESSADMD	SYNM	1201	O15061
ADIDSGLSPSIPMAS	TADA2A	341	O75478
ASAEAPGEPSDMLAS	SLC26A9	641	Q7LBE3
MSGLGDSSSDPANPD	NCOA1	1	Q15788
GTTTGTAMDDADPPG	HID1	306	Q8IV36
VAPSPSDMGAGTAAS	NCAN	451	O14594
METGPSEEPSGRKES	HOATZ	1	Q6PI97
DPGAQEMSESSSTPG	NGEF	121	Q8N5V2
DDTDPVPRGAGSAMS	SNAP29	171	O95721
DSLEAMSEGDAPTPF	KIAA1217	146	Q5T5P2
LSFAPPMSDRSGDGI	SIN3B	371	O75182
SAVSSAGAGPPAMLD	MYBPH	146	Q13203
SGAEGLSNPEMLTPS	PKHD1	2306	P08F94
MPSPVDASSADGGSG	SEBOX	1	Q9HB31
KGLSGAPSPTMSEDS	SOX9	16	P48436
GMSEAGIPQSPDDSD	SUPT7L	371	O94864
SPSEDLLSGLGDMTS	AKAP6	231	Q13023
SGMVSGIISPSDLPD	APC	1411	P25054
AGLDDEDDTSIGMPS	RETREG3	341	Q86VR2
MDLVGVASPEPGTAA	RIOK3	1	O14730
GDMDLSGLPETAVDS	RAPGEF2	71	Q9Y4G8
METGVSPATAEGPEN	TMEM268	236	Q5VZI3
RMKPPEEGTETSGDS	TSPY9	296	A0A494C1R9
EPGGPGAMTESLEAS	RSPH3	486	Q86UC2
PVGSDSSSIPDDMGS	ZFHX4	1456	Q86UP3
RMKPPEEGTETSGDS	TSPY4	296	P0CV99
SALSGAPRETPSEMA	TTBK1	996	Q5TCY1
MAEAEESPGDPGTAS	YIPF6	1	Q96EC8
GSSGDRPEASMTPDA	SPIRE2	506	Q8WWL2
MNGFSTEEDSREGPP	SAP30L	1	Q9HAJ7
GSDASGPDPQLAVTM	WDR70	11	Q9NW82
MAEGVPASPSSGEGS	RFX8	1	Q6ZV50
ETSASELERMNPGPG	SLC19A1	221	P41440
VDLEPGTMDSVHSGP	TUBB8B	66	A6NNZ2
MAEAGTGEPSPSVEG	TSSC4	1	Q9Y5U2
MEPGGEPTGAKESST	ZNF696	1	Q9H7X3
MSSAAGPDPSEAPEE	YJEFN3	1	A6XGL0
SSPGEESEVGSMVGE	PRRC2B	1546	Q5JSZ5
DSLPTTGDAGGREPM	GTF3C4	651	Q9UKN8
DVSSPLTEGAGSPMS	nan	131	Q6ZVQ6
MFEPSSPGAGEADTE	PLCB1	496	Q9NQ66
GPDSPACLEGEMGTS	ZNF469	2331	Q96JG9
GLEMPAPADDSSSSL	ZNF469	2971	Q96JG9
SSSLLEPSEMGRGTP	ATP6V0A1	151	Q93050
MQTSEREGSGPELSP	ZFYVE27	1	Q5T4F4
SESPEGSPFRDMDDG	UBN1	321	Q9NPG3
LEEPGMLLGSPAGSS	ZSCAN18	131	Q8TBC5
TDSPQGGMPSSREDF	ZNF217	251	O75362
SSGLGAEEPLSSMTD	PIEZO1	1591	Q92508
PELMSGANDVSSLGP	UGGT2	1021	Q9NYU1
PASLPSAMGGGEDEE	TIGD5	561	Q53EQ6
EDPAGTPAVDALTSM	PRR23C	46	Q6ZRP0
MADSSEGPRAGPGEV	TRPV4	1	Q9HBA0
MPSPAGSQELSSRGE	ZNF185	266	O15231
TDKSGISMDDFTPPG	THAP4	211	Q8WY91
DSMDGELGLDSGPSD	ZNF282	381	Q9UDV7
AEADKMSGTSTPGPS	TRIO	2361	O75962
DPMSSSFDLDPDVIG	ZNF358	86	Q9NW07
AGSGPPATEGSMDTL	TSPYL5	191	Q86VY4
SGADTTQPGMEVDAP	ZBTB3	241	Q9H5J0
EDPGTGMGSSLATAE	KMT2D	2646	O14686
LATAELPGTQDPGMS	KMT2D	2656	O14686